Recall: Hospira Lidocaine Injection

The FDA has announced a recall of another lot of Hospira Lidocaine because of a potentially dangerous reddish orange particulate.  This time it’s 1% Lidocaine HCI Injection, USP, 10mg/mL, 30 mL single dose, preservative-free, lot #31-427-DK, Expiration Date 1JUL2015.  For details see http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm394026.htm.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s